Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 44
Filter
1.
Semin Cancer Biol ; 60: 324-333, 2020 02.
Article in English | MEDLINE | ID: mdl-31647982

ABSTRACT

The macro-metastasis/organ parenchyma interface (MMPI) was previously considered an inert anatomical border which sharply separates the affected organ parenchyma from the macro-metastatic tissue. Recently, infiltrative growth of macro-metastases from various primary tumors was described in the brain, liver and lung, with significant impact on survival. Strikingly, the MMPI patterns differed between entities, so that at least nine different patterns were described. The MMPI patterns could be further classified into three major groups: displacing, epithelial and diffuse infiltrating. Additionally, macro-metastases are a source of further tumor cell dissemination in the affected organ; and these intra-organ metastatic dissemination tracks starting from the MMPI also vary depending on the anatomical structures of the colonized organ and influence disease outcome. In spite of their relevance, MMPIs and organ-specific dissemination tracks are still largely overlooked by many clinicians, pathologists and/or researchers. In this review, we aim to address this important issue and enhance our current understanding of the different MMPI patterns and dissemination tracks in the brain, liver and lung.


Subject(s)
Neoplasms/diagnosis , Humans , Neoplasm Invasiveness , Neoplasm Metastasis , Neoplasm Staging , Neoplasms/etiology , Neoplasms/metabolism , Organ Specificity
2.
Acta Biomater ; 85: 60-74, 2019 02.
Article in English | MEDLINE | ID: mdl-30500445

ABSTRACT

Surgical meshes are frequently used for the treatment of abdominal hernias, pelvic organ prolapse, and stress urinary incontinence. Though these meshes are designed for tissue reinforcement, many complications have been reported. Both differentiated cell- and mesenchymal stem cell-based therapies have become attractive tools to improve their biocompatibility and tissue integration, minimizing adverse inflammatory reactions. However, current studies are highly heterogeneous, making it difficult to establish comparisons between cell types or cell coating methodologies. Moreover, only a few studies have been performed in clinically relevant animal models, leading to contradictory results. Finally, a thorough understanding of the biological mechanisms of mesenchymal stem cells in the context of foreign body reaction is lacking. This review aims to summarize in vitro and in vivo studies involving the use of differentiated and mesenchymal stem cells in combination with surgical meshes. According to preclinical and clinical studies and considering the therapeutic potential of mesenchymal stem cells, it is expected that these cells will become valuable tools in the treatment of pathologies requiring tissue reinforcement. STATEMENT OF SIGNIFICANCE: The implantation of surgical meshes is the standard procedure to reinforce tissue defects such as hernias. However, an adverse inflammatory response secondary to this implantation is frequently observed, leading to a strong discomfort and chronic pain in the patients. In many cases, an additional surgical intervention is needed to remove the mesh. Both differentiated cell- and stem cell-based therapies have become attractive tools to improve biocompatibility and tissue integration, minimizing adverse inflammatory reactions. However, current studies are incredibly heterogeneous and it is difficult to establish a comparison between cell types or cell coating methodologies. This review aims to summarize in vitro and in vivo studies where differentiated and stem cells have been combined with surgical meshes.


Subject(s)
Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells/cytology , Surgical Mesh , Animals , Foreign-Body Reaction/pathology , Humans , Inflammation/pathology , Mesenchymal Stem Cell Transplantation/adverse effects , Prostheses and Implants
3.
Sci Rep ; 8(1): 9207, 2018 06 15.
Article in English | MEDLINE | ID: mdl-29907808

ABSTRACT

Outbreaks of locust populations repeatedly devastate economies and ecosystems in large parts of the world. The consequent behavioural shift from solitarious to gregarious and the concomitant changes in the locusts' biology are of relevant scientific interest. Yet, research on the main locust species has not benefitted from recent advances in genomics. In this first RNA-Seq study on Schistocerca gregaria, we report two transcriptomes, including many novel genes, as well as differential gene expression results. In line with the large biological differences between solitarious and gregarious locusts, almost half of the transcripts are differentially expressed between their central nervous systems. Most of these transcripts are over-expressed in the gregarious locusts, suggesting positive correlations between the levels of activity at the population, individual, tissue and gene expression levels. We group these differentially expressed transcripts by gene function and highlight those that are most likely to be associated with locusts' phase change either in a species-specific or general manner. Finally, we discuss our findings in the context of population-level and physiological events leading to gregariousness.


Subject(s)
Central Nervous System/metabolism , Gene Expression Regulation/physiology , Grasshoppers , Sequence Analysis, RNA , Transcriptome/physiology , Animals , Grasshoppers/genetics , Grasshoppers/metabolism
4.
Sci Rep ; 7(1): 6653, 2017 07 27.
Article in English | MEDLINE | ID: mdl-28751682

ABSTRACT

We analyze the evolutionary relationships and expression patterns of the large set of genes for chemosensory proteins (CSPs) in the two main pest locusts. We used the available transcriptome and genome data to infer the number of genes using BLAST searches and sequence similarity matrices. Maximum likelihood phylogenies revealed the relationships between these CSPs and CSPs from several arthropods. RNAseq and qPCR allowed associating CSPs to locust phases. Crossing the phylogenetic and expression data allowed us to deduce homologies and conservation of the involvement in the phase change. We confirm that Locusta migratoria has at least 58 CSP gene copies, only five of which lack evidence of expression, and we reveal that Schistocerca gregaria has at least 42 expressed CSP genes. Both species share 21 orthologs, whereas 33 L. migratoria and 15 S. gregaria CSPs seem species-specific. Additional six S. gregaria and four L. migratoria CSPs seem duplications. Although the expression profiles are not especially conserved, seven orthologous CSP pairs share a gregarious over-expression pattern in adult locusts. We thus confirm that the number of locusts' CSPs is large, due to gene duplications during the evolution of Orthoptera, we establish sequence and potential functional homologies, and we highlight specific CSPs that appear to be involved in locust gregariousness either in general or in a species-specific manner.


Subject(s)
Evolution, Molecular , Grasshoppers/genetics , Insect Proteins/genetics , Animals , Gene Expression , Gene Expression Profiling , Grasshoppers/metabolism , Locusta migratoria/genetics , Locusta migratoria/metabolism , Phylogeny , Species Specificity
7.
Rehabilitación (Madr., Ed. impr.) ; 49(3): 144-149, jul.-sept. 2015. tab
Article in Spanish | IBECS | ID: ibc-136888

ABSTRACT

Objetivo. Identificar qué variables se relacionaban con la respuesta a un programa de rehabilitación cognitiva en una población de pacientes con daño cerebral adquirido. Material y métodos. En este estudio retrospectivo participaron 528 pacientes con daño cerebral adquirido que recibieron rehabilitación cognitiva en nuestro centro entre febrero de 2008 y enero de 2013. Mediante análisis de regresión logística se analizó la respuesta al tratamiento (variable dependiente). La respuesta al tratamiento se calculó a partir de las diferencias entre las exploraciones neuropsicológicas pre- y post-tratamiento para las variables atención, memoria y funciones ejecutivas. Resultados. La edad en el momento de la lesión (OR = 0,97; 95% CI: 0,96-0,98) y el lugar donde se realizó el tratamiento (OR = 0,45; 95% CI: 0,27-0,73) se asociaron positivamente con una mejor respuesta al tratamiento para el índice atencional. En el caso del índice mnésico fueron la edad (OR = 0,98; 95% CI: 0,96-0,99), etiología (OR = 0,63; 95% CI: 0,39-1) y lugar de realización del tratamiento (OR = 0,48; 95% CI: 0,29-0,79); tales variables también resultaron significativas para el índice ejecutivo. Conclusiones. Los resultados sugieren que parte de las diferencias interindividuales observadas en la respuesta al tratamiento cognitivo en pacientes con daño cerebral adquirido podrían ser explicadas por las variables edad, etiología y lugar de realización del tratamiento (AU)


Objective. To identify the variables related to response to a cognitive rehabilitation program in a population of patients with acquired brain injury. Material and methods. This retrospective study included 528 patients with acquired brain injury who received cognitive rehabilitation at our center between February 2008 and January 2013. We used logistic regression analysis to examine the impact of predictive variables on treatment response (dependent variable). Differences between pre- and post-treatment neuropsychological assessment were used to calculate treatment response in the domains of attention, memory, and executive function. Results. For the attention index, the variables positively associated with better treatment response were age at the time of injury (OR = 0.97, 95% CI: 0.96-0.98) and place of treatment (OR = 0.45, 95% CI: 0.27-0.73). For the memory index, the variables positively associated with better treatment response were age (OR = 0.98, 95% CI: 0.96 to 0.99), etiology (OR = 0.63, 95% CI: 0.39 to 1) and place of treatment (OR = 0.48, 95% CI: 0.29 to 0.79); these variables were also significant for the executive index. Conclusions. These findings suggest that part of the inter-individual differences in response to cognitive rehabilitation in patients with acquired brain injury could be explained by age, etiology and place of treatment (AU)


Subject(s)
Adult , Female , Humans , Male , Brain Damage, Chronic/rehabilitation , Brain Damage, Chronic/therapy , Cognitive Dissonance , Brain Damage, Chronic/physiopathology , Retrospective Studies , Logistic Models , Odds Ratio , Multivariate Analysis
10.
Ginecol Obstet Mex ; 83(6): 356-62, 2015 Jun.
Article in Spanish | MEDLINE | ID: mdl-26285487

ABSTRACT

UNLABELLED: The intra-abdominal umbilical vein varix is very uncommon, characterized by a dilation of the vein, usually located between its entry into the abdomen and completion in the portal system. However, the location of this anomaly to extra-abdominal level is very unusual and more difficult to diagnose by ultrasound. CLINICAL CASE: We present a case undiagnosed during pregnancy, demonstrating cord abnormality in its extra-abdominal portion and confirmed later by the pathology study. It was a gestation of 36 + 6 weeks, ending by performing emergency caesarean section for abnormal fetal heart rate, with good perinatal outcome. The diagnosis was made after placental delivery, by the existence of fibrotic cystic structure in the middle third of the umbilical cord.


Subject(s)
Abdomen/blood supply , Pregnancy Outcome , Umbilical Veins/abnormalities , Varicose Veins/pathology , Adult , Cesarean Section , Female , Heart Rate, Fetal , Humans , Pregnancy , Umbilical Cord/pathology
11.
Chromosoma ; 124(2): 263-75, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25472934

ABSTRACT

The desert locust (Schistocerca gregaria) has been used as material for numerous cytogenetic studies. Its genome size is estimated to be 8.55 Gb of DNA comprised in 11 autosomes and the X chromosome. Its X0/XX sex chromosome determinism therefore results in females having 24 chromosomes whereas males have 23. Surprisingly, little is known about the DNA content of this locust's huge chromosomes. Here, we use the Feulgen Image Analysis Densitometry and C-banding techniques to respectively estimate the DNA quantity and heterochromatin content of each chromosome. We also identify three satellite DNAs using both restriction endonucleases and next-generation sequencing. We then use fluorescent in situ hybridization to determine the chromosomal location of these satellite DNAs as well as that of six tandem repeat DNA gene families. The combination of the results obtained in this work allows distinguishing between the different chromosomes not only by size, but also by the kind of repetitive DNAs that they contain. The recent publication of the draft genome of the migratory locust (Locusta migratoria), the largest animal genome hitherto sequenced, invites for sequencing even larger genomes. S. gregaria is a pest that causes high economic losses. It is thus among the primary candidates for genome sequencing. But this species genome is about 50 % larger than that of L. migratoria, and although next-generation sequencing currently allows sequencing large genomes, sequencing it would mean a greater challenge. The chromosome sizes and markers provided here should not only help planning the sequencing project and guide the assembly but would also facilitate assigning assembled linkage groups to actual chromosomes.


Subject(s)
Chromosomes/genetics , Genome, Insect , Grasshoppers/genetics , Repetitive Sequences, Nucleic Acid , Animals , Chromosome Mapping , DNA, Ribosomal/genetics , DNA, Satellite/genetics , Female , Heterochromatin/genetics , Heterochromatin/metabolism , High-Throughput Nucleotide Sequencing , Histones/genetics , In Situ Hybridization, Fluorescence , Male , Sequence Analysis, DNA
12.
Rehabilitación (Madr., Ed. impr.) ; 45(1): 49-56, ene.-mar. 2011. tab, ilus
Article in Spanish | IBECS | ID: ibc-86081

ABSTRACT

Introducción. El traumatismo craneoencefálico (TCE) es la causa más común de discapacidad en las primeras décadas de la vida y sus secuelas comprenden cambios motores, conductuales y cognitivos. Medir estos cambios es un aspecto esencial en la rehabilitación para identificar objetivos, cuantificar secuelas y crear planes de intervención. El objetivo de este estudio es evaluar la funcionalidad tras un programa de rehabilitación empleando la Clasificación Internacional de la Funcionalidad (CIF) como marco conceptual. Material y método. Se revisaron retrospectivamente los resultados funcionales de 77 pacientes con TCE grave según la escala FIM FAM expresados en la nomenclatura de la CIF siguiendo la metodología de las linking rules. Resultados. Sólo un 3,8% del total de la CIF se evalúa mediante la FIM FAM. Se pudo traducir la mayoría de los conceptos a la nomenclatura de la CIF, pero es notoria la ausencia de factores medioambientales. A nivel cognitivo, el deterioro fue máximo en las categorías de solución de problemas (81,8%), empleabilidad (77,9%) y juicio (77,9%). Subir escaleras (85,7%) y movilidad comunitaria (81,8%) fueron las más afectadas a nivel motor. Conclusiones. El uso de la CIF como marco conceptual permite describir el estado de salud de individuos como TCE y conceptualmente es capaz de detectar limitaciones como la ausencia de factores medioambientales(AU)


Introduction. Traumatic Brain Injury (TBI) is the leading cause of disability in the first decades of life. Motor, cognitive and behavioral changes are examples of its sequelae. The measurement of these changes are essential aspects of rehabilitation in order to identify objectives, quantify problems and plan interventions. The objective of this study is to evaluate functioning after a rehabilitation programme using the International Classification of Functioning (ICF) as a conceptual framework. Material and method. The outcome of 77 patients with severe TBI were retrospectively analyzed using the FIM FAM scale expressed in terms of ICF coding following the methodology of the «linking rules.» Results. Only 3.8% of the ICF are evaluated by the FIM FAM. Most of the concepts could translated into the ICF language. However, the lack of environmental factors stands out. The most affected cognitive areas were problem solving (81.8%), employability (77.9%) and judgment with a 77.9% of patients showing problem (4). Climbing stairs (85.7%) and Community mobility (81.8%) were the mostly affected motor functions. Conclusions. The use of ICF as a conceptual framework allows to describe the health status of a TBI patient and it is conceptually capable of detecting limitations such as a lack in evaluating environmental factors(AU)


Subject(s)
Humans , Male , Female , International Classification of Functioning, Disability and Health , Disability Evaluation , Head Injuries, Penetrating/epidemiology , Head Injuries, Penetrating/rehabilitation , Retrospective Studies , Data Collection/instrumentation , Data Collection/methods
13.
Antiviral Res ; 85(2): 403-8, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19941906

ABSTRACT

BACKGROUND: Although efavirenz and lopinavir/ritonavir(r) are both recommended antiretroviral agents in antiretroviral-naïve HIV-infected patients, there are few randomized comparisons of their efficacy and tolerability. METHODS: A multicenter and randomized study was performed including 126 antiretroviral-naïve patients, randomly assigned to efavirenz+Kivexa (n=63) or lopinavir/r+Kivexa (n=63). Efficacy endpoints were the percentage of patients with HIV-RNA < or =50 copies/mL at week 48 and CD4 recovery. Safety was assessed by comparing toxicity and discontinuations. Statistical analyses were performed on an intention-to-treat (ITT) basis (Missing=Failure). RESULTS: At week 48, 56.7% of patients in the efavirenz and 63.2% in the lopinavir/r groups showed HIV-1 RNA <50 copies/mL (P=0.770) (intention-to-treat analysis; Missing=Failure). Only 1 (1.53%) patient from each group experienced virological failure. CD4 values increased in both groups (298 cells in the efavirenz group, P=0.001; 249 cells in the lopinavir/r group, P=0.002; P=0.126 between groups). HDL-cholesterol only increased in the efavirenz group (from 39+/-12 mg/dL to 49+/-11; P=0.001). Discontinuations were more frequent in the lopinavir/r group (36.5% versus 28.5%; P=0.193), but more patients with efavirenz interrupted due to toxicity (11.1% versus 6.3%); most of them were attributed to hypersensitivity reaction. CONCLUSIONS: Similar virological efficacy was observed for efavirenz and lopinavir/r, when administered with Kivexa in antiretroviral-naïve patients, while immunological improvement was slightly superior for efavirenz. The higher rate of discontinuation due to toxicity in the efavirenz group was related to a higher incidence of hypersensitivity reaction. Nowadays, the use of the new formulation of lopinavir/r and the HLA-B*5701 genotype test before starting abacavir should improve the safety profiles of these regimens.


Subject(s)
Anti-HIV Agents/therapeutic use , Benzoxazines/therapeutic use , HIV Infections/drug therapy , Pyrimidinones/therapeutic use , Ritonavir/therapeutic use , Adult , Alkynes , Anti-HIV Agents/adverse effects , Benzoxazines/adverse effects , CD4 Lymphocyte Count , Cyclopropanes , Dideoxynucleosides , Drug Combinations , Drug Hypersensitivity , Female , Humans , Lamivudine/adverse effects , Lopinavir , Male , Middle Aged , Pyrimidinones/adverse effects , RNA, Viral/blood , Ritonavir/adverse effects , Treatment Outcome , Viral Load , Withholding Treatment/statistics & numerical data
14.
Bioresour Technol ; 100(1): 97-103, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18657415

ABSTRACT

In upflow anaerobic sludge blanket (UASB) digesters treating raw sewage at low temperatures, the sludge progressively lost methanogenic activity, indicating the possibility of methanogenic activity inhibition caused by wastewater constituents. To check this fact, batch and semi-continuous methanogenic toxicity assays were carried out with raw and centrifuged sewage. Permanent methanogenic toxicity on anaerobic sludge of approximately 50% was found when the sludge exposure to wastewater was renewed in a semi-continuous way. A stronger methanogenic inhibition of about 70-100% was observed when an active anaerobic sludge was exposed to mixed liquor from the UASB digester treating municipal wastewater. Suspended solids removal from sewage slightly reduced methanogenic toxicity. Effective concentration of municipal wastewater that caused a 50% reduction in methanogenic activity was estimated to be in the range of 150-200 mg CODl(-1). As methanogenic inhibition appeared to be related to remaining COD, higher methanogenic toxicity in digesters operating with low conversion efficiency will be expected.


Subject(s)
Bacteria, Anaerobic/drug effects , Bacteria, Anaerobic/metabolism , Bioreactors/microbiology , Methane/administration & dosage , Methane/metabolism , Sewage/microbiology , Water Pollutants, Chemical/metabolism , Cell Survival/drug effects , Cities
15.
AIDS Care ; 20(7): 796-805, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18728987

ABSTRACT

The objective of this study was to assess adherence of HIV-1-infected patients who started treatment in the pre-HAART era and to determine variables associated with better adherence, including relevant attitudes and beliefs. This is a cross-sectional study enrolling patients who had received antiretroviral therapy for >or=10 years. Adherence was evaluated through self-reporting and plasma drug concentrations. Treatment variables, attitudes and beliefs were collected during structured interviews. The results show that for 87 patients the median (interquartile range) time on therapy was 13 (10-19) years; 80 were on therapy at the time of analysis. Adherence was >or=95% in 54 patients (67.5%), 90-94% in 22 (27.5%) and <90% in 4 (5%). Drug concentrations were below the lower limit of detection in five patients. Younger age (p=0.014), female gender (p=0.005), current substance abuse (p=0.004) and hepatitis C virus co-infection (p<0.001) were related to lower adherence. Adherence did not differ in relation to different drug families or once- or twice-daily regimens. Patients with adherence <95% were more likely to have interrupted treatment without doctor's recommendation (p=0.009). Adherent patients exhibited a higher perception of risk of developing the illness and of benefits of therapy, higher self-efficacy and intention to adhere and were more influenced by events that motivate medication intake. To conclude, adherence was >90% in most patients on antiretroviral therapy for >or=10 years. Adherence was more related to beliefs about health and illness than to the characteristics of medication or level of knowledge about treatment. Care adherence interventions should include assessment of health beliefs.


Subject(s)
Antiretroviral Therapy, Highly Active , Attitude to Health , HIV Infections/drug therapy , HIV-1 , Patient Compliance/statistics & numerical data , Adult , Cross-Sectional Studies , Drug Administration Schedule , Female , HIV Infections/psychology , HIV Long-Term Survivors , Humans , Male , Middle Aged , Spain , Treatment Outcome
16.
Environ Technol ; 28(9): 1063-72, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17910259

ABSTRACT

Centralised treatment of domestic sewage coming from A Coruña city (250000 inhabitants) and several medium and small size villages (up to 15000 inhabitants) together with industrial estate effluents was planned. The area population is about 380000 inhabitants and the overall effluent will reach about 600000 equivalent inhabitants. The characteristics of different streams will determine the treatment alternatives and pre-treatment requirements for individual streams. Domestic sewage from A Coruña showed medium to high organic content (741 mg l(-1) of COD), while domestic sewage from small villages (Lorbé, Oleiros) and industrial estates (Sabón, A Grela) showed a high variability in organic content, with COD concentration ranging from 100 to 4000 mg L(-1) or more. About 50-65% COD corresponded to suspended solids, although some industrial effluents showed lower values. Characterized industrial effluents had lower concentration of nutrients (nitrogen and phosphorus) and higher concentration of sulphate and alkalinity than domestic sewage. Anaerobic biodegradability was about 80% for domestic sewage, and ranged from 20 to 100% for industrial estate effluents. Furthermore, some industrial streams showed high microbial toxicity. The results indicate that anaerobic treatment of these effluents is of interest. However, specific pre-treatment for some individual streams or the adoption of minimisation and prevention measures in order to reach total or partial detoxification is suggested.


Subject(s)
Bioreactors , Industrial Waste , Sewage , Waste Disposal, Fluid/methods , Anaerobiosis , Carbohydrates/analysis , Lipids/analysis , Methane/metabolism , Methane/toxicity , Nitrogen/analysis , Nitrogen/metabolism , Phosphorus/analysis , Phosphorus/metabolism , Proteins/analysis , Sewage/analysis , Spain , Sulfates/analysis , Sulfates/metabolism , Water Pollutants/analysis , Water Pollutants/metabolism
17.
Med. paliat ; 13(2): 100-104, feb. 2006. tab
Article in Es | IBECS | ID: ibc-047772

ABSTRACT

Objetivo: revisar la información disponible en MEDLINE, en los últimos diez años, con el fin de intentar extraer algunas recomendaciones sobre el uso de opioides inhalados en el manejo de la disnea de pacientes con neoplasias avanzadas. Material y método: se realizó una búsqueda en MEDLINE con las palabras clave «neoplasm», «dyspnea» y «analgesic, opioid» incluyéndose sólo los estudios clínicos o metanálisis, en que la población de estudio fuesen pacientes con cáncer avanzado y terminal y que empleen el opioide nebulizado. Resultados: se analizan los 4 artículos evaluables tras la búsqueda, 1 ensayo clínico randomizado y 3 no randomizados. No son estudios comparables entre sí dado lo heterogéneo de las variables medidas y de las herramientas de medida. La mayor limitación es el pequeño tamaño de las muestras. El grado de evidencia es fundamentalmente un IIa. Conclusiones: a) los opioides inhalados son eficaces en el manejo de la disnea en pacientes con cáncer avanzado y terminal, obteniendo mayor beneficio los tratados previamente con opioides por otras vías; b) los opioides han de diluirse en suero salino y han de administrarse nebulizados en una mascarilla facial; c) sería recomendable realizar, al menos, una prueba terapéutica con morfina o fentanilo inhalado para valorar la respuesta de nuestros pacientes; y d) sería necesario continuar investigando, para valorar tanto otros opiáceos como dosis, frecuencia y duración óptima del tratamiento y finalmente comparar los distintos opioides (AU)


Objective: to check the information available in MEDLINE for the last ten years in order to make recommendations on the use of nebulized opioids for the treatment of dyspnea in patients with advanced cancer. Material and method: a computerized literature search of MEDLINE was undertaken using the following search words - «neoplasm», «dyspnea», and «analgesic, opioids». The search was limited to clinical trials or meta-analyses addressing nebulized therapies for dyspnea in patients with advanced cancer. Results: the full manuscripts of articles found were requested and analyzed - 1 randomized and 3 non-randomized clinical trials. The analysis was complex because of the presence of heterogeneous variables and outcome measures. A major limitation was the small size of samples. Evidence level was basically IIa. Conclusions: a) nebulized opioids are useful for the treatment of dyspnea in patients with advanced and terminal cancer. Patients on systemic opioids had a tendency to benefit from nebulized morphine or fentanyl when compared to patients not on opioids; b) opioids were dissolved in normal saline and given through a nebulizer; c) it was recommended that at least a therapeutic test with nebulized morphine or fentanyl was attempted to assess patient response; and d) further research is needed regarding other opioids (for example, methadone). Optimum dose and treatment duration need also be established, and a comparison between different opioids is also warranted (AU)


Subject(s)
Humans , Palliative Care/methods , Narcotics/administration & dosage , Dyspnea/drug therapy , Administration, Inhalation
18.
Clin Microbiol Infect ; 11(11): 919-24, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16216109

ABSTRACT

A retrospective study of Streptococcus pneumoniae bacteraemia among adult patients in two large teaching hospitals in Spain identified 108 (10.6%) of 1,020 episodes as nosocomial pneumococcal bloodstream infections (NPBIs). Seventy-seven clinical records with sufficient data were available for analysis. The interval between admission and a positive blood culture was 3--135 days (median 17 days; interquartile range 8--27). The main underlying and predisposing conditions for NPBI were malignancy (31%), chronic obstructive pulmonary disease (28.6%), heart failure (16.9%), chronic renal failure (15.6%), liver cirrhosis (13%) and infection with human immunodeficiency virus (13%). Overall, 31.2% of patients developed severe sepsis, 11.7% septic shock, and 3.9% multi-organ failure. The main portals of entry were pneumonia (70.1%), meningitis (5.2%) and primary peritonitis (5.2%). Of the responsible serogroups, 78% were included in the 23-valent polysaccharide vaccine. Thirty-five (45.5%) patients died, with death considered to be related to the NPBI in 21 (27.3%) cases. Following multivariate analysis, factors that independently predicted death after adjusting for age were: ultimately fatal underlying disease (OR, 8.9; 95% CI, 0.8--94.3; p<0.001); rapidly fatal underlying disease (OR, 15.0; 95% CI, 2.8--81.3; p<0.001); heart failure (OR, 8.11; 95% CI, 1.1--60.8; p<0.03); inadequate empirical therapy (OR, 10.6; 95% CI, 1.2--97; p<0.003); a severe sepsis score (OR, 9.5; 95% CI, 1.9--47.0; p<0.001); and septic shock or multi-organ failure (OR, 63.7; 95% CI, 4.9--820.7; p<0.001). Adequate empirical therapy was an independent protective factor (OR, 0.05; 95% CI, 0.04--0.58; p<0.005), but the use of more than one antimicrobial agent was not.


Subject(s)
Bacteremia/microbiology , Cross Infection , Pneumococcal Infections , Streptococcus pneumoniae/isolation & purification , Adult , Blood/microbiology , Cross Infection/drug therapy , Cross Infection/epidemiology , Cross Infection/microbiology , HIV Infections/complications , Heart Failure/complications , Hospitals, Teaching , Humans , Inpatients , Kidney Failure, Chronic/complications , Liver Cirrhosis/complications , Meningitis/microbiology , Multiple Organ Failure , Neoplasms/complications , Peritonitis/microbiology , Pneumococcal Infections/drug therapy , Pneumococcal Infections/epidemiology , Pneumococcal Infections/microbiology , Pneumonia, Pneumococcal , Pulmonary Disease, Chronic Obstructive/complications , Retrospective Studies , Risk Factors , Shock, Septic , Spain/epidemiology , Treatment Outcome
19.
Eur J Clin Microbiol Infect Dis ; 24(7): 488-91, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15997369

ABSTRACT

Presented here are the results of Legionella urinary antigen testing correlated with patient characteristics and severity of pneumonia (Fine score) in 295 patients diagnosed with Legionella pneumonia in connection with a large outbreak in Murcia, Spain. Overall, the sensitivity of the urinary antigen test was 47.7% (141/295). A statistically significant association was found between the clinical severity of pneumonia and test sensitivity; 85.7% for patients with severe pneumonia versus 37.9% for patients with mild pneumonia (risk ratio, 2.3). Variables significantly associated with test positivity in multivariate analysis were as follows: pre-existing pulmonary disease, body temperature >40 degrees C, leukocytosis and multilobar infiltrates. Patients with mild pneumonia may go undiagnosed if the urinary antigen test is used alone.


Subject(s)
Antigens, Bacterial/urine , Disease Outbreaks , Legionnaires' Disease/diagnosis , Legionnaires' Disease/physiopathology , Legionnaires' Disease/urine , Biomarkers/urine , Female , Humans , Male , Middle Aged , Sensitivity and Specificity , Severity of Illness Index , Spain/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...